1. Home
  2. ZLAB vs ATMU Comparison

ZLAB vs ATMU Comparison

Compare ZLAB & ATMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ATMU
  • Stock Information
  • Founded
  • ZLAB 2013
  • ATMU 1958
  • Country
  • ZLAB China
  • ATMU United States
  • Employees
  • ZLAB N/A
  • ATMU 4500
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ATMU Auto Parts:O.E.M.
  • Sector
  • ZLAB Health Care
  • ATMU Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • ATMU Nasdaq
  • Market Cap
  • ZLAB 3.0B
  • ATMU 3.6B
  • IPO Year
  • ZLAB 2017
  • ATMU 2023
  • Fundamental
  • Price
  • ZLAB $26.67
  • ATMU $43.17
  • Analyst Decision
  • ZLAB Strong Buy
  • ATMU Buy
  • Analyst Count
  • ZLAB 4
  • ATMU 5
  • Target Price
  • ZLAB $52.50
  • ATMU $44.80
  • AVG Volume (30 Days)
  • ZLAB 1.1M
  • ATMU 833.6K
  • Earning Date
  • ZLAB 11-12-2024
  • ATMU 11-08-2024
  • Dividend Yield
  • ZLAB N/A
  • ATMU 0.46%
  • EPS Growth
  • ZLAB N/A
  • ATMU 3.84
  • EPS
  • ZLAB N/A
  • ATMU 2.15
  • Revenue
  • ZLAB $355,748,000.00
  • ATMU $1,662,600,000.00
  • Revenue This Year
  • ZLAB $48.50
  • ATMU $4.23
  • Revenue Next Year
  • ZLAB $47.37
  • ATMU $3.42
  • P/E Ratio
  • ZLAB N/A
  • ATMU $20.04
  • Revenue Growth
  • ZLAB 35.01
  • ATMU 3.04
  • 52 Week Low
  • ZLAB $13.48
  • ATMU $20.44
  • 52 Week High
  • ZLAB $36.60
  • ATMU $44.66
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 41.98
  • ATMU 68.68
  • Support Level
  • ZLAB $27.74
  • ATMU $42.12
  • Resistance Level
  • ZLAB $32.15
  • ATMU $44.66
  • Average True Range (ATR)
  • ZLAB 1.36
  • ATMU 1.16
  • MACD
  • ZLAB -0.64
  • ATMU 0.31
  • Stochastic Oscillator
  • ZLAB 3.15
  • ATMU 83.99

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

About ATMU Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. It designs and manufactures advanced filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. Atmus offers products for first-fit and aftermarket applications including air filters, fuel filters, fuel water separators, lube filters, hydraulic filters, coolants, fuel additives, and other filtration systems to original equipment manufacturers, dealers/distributors, and end-users.

Share on Social Networks: